ICUI241220C140000
- 0.00
- 0.000.00%
ICU Medical Newsroom
A Glimpse Into The Expert Outlook On ICU Medical Through 4 Analysts
Jefferies Maintains ICU Medical(ICUI.US) With Buy Rating, Maintains Target Price $200
Jefferies Upgrades ICU Medical(ICUI.US) to Buy Rating, Raises Target Price to $200
Express News | ICU Medical Inc : Jefferies Raises to Buy From Hold
KeyBanc Maintains ICU Medical(ICUI.US) With Buy Rating, Announces Target Price $209
ICU Medical Insider Sold Shares Worth $1,954,935, According to a Recent SEC Filing
Insider Sale: Chief Operating Officer of $ICUI (ICUI) Sells 206 Shares
Express News | FDA: Smiths Medical Updates Instructions for Cadd-Solis Li-Ion Rechargeable Battery Packs Over Potential Pack Damage Preventing Recharge - Website
Earnings Update: Here's Why Analysts Just Lifted Their ICU Medical, Inc. (NASDAQ:ICUI) Price Target To US$199
ICU Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
ICU Medical, Otsuka Team up to Boost US IV Solutions Production
Breaking Down ICU Medical: 4 Analysts Share Their Views
ICU Medical Analyst Ratings
KeyBanc Maintains ICU Medical(ICUI.US) With Buy Rating
Needham Maintains ICU Medical(ICUI.US) With Hold Rating
Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), ICU Medical (ICUI) and Lexicon Pharmaceuticals (LXRX)
Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX), Legend Biotech (LEGN) and ICU Medical (ICUI)
Express News | ICU Medical Inc : Jefferies Raises Target Price to $200 From $183
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript Summary
ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript